Novel EGFR inhibitors attenuate cardiac hypertrophy induced by angiotensin II

Cardiac hypertrophy is an important risk factor for heart failure. Epidermal growth factor receptor (EGFR) has been found to play a role in the pathogenesis of various cardiovascular diseases. The aim of this current study was to examine the role of EGFR in angiotensin II (Ang II)‐induced cardiac hy...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Cell Mol Med
Hlavní autoři: Peng, Kesong, Tian, Xinqiao, Qian, Yuanyuan, Skibba, Melissa, Zou, Chunpeng, Liu, Zhiguo, Wang, Jingying, Xu, Zheng, Li, Xiaokun, Liang, Guang
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2016
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4759478/
https://ncbi.nlm.nih.gov/pubmed/26762600
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.12763
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky